Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-13-393080
Filing Date
2013-10-07
Accepted
2013-10-07 16:56:21
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d607803ds3.htm S-3 361303
2 EX-4.12 d607803dex412.htm EX-4.12 278987
3 EX-4.15 d607803dex415.htm EX-4.15 92998
4 EX-4.16 d607803dex416.htm EX-4.16 92572
5 EX-4.17 d607803dex417.htm EX-4.17 80852
6 EX-12.1 d607803dex121.htm EX-12.1 31177
7 EX-23.1 d607803dex231.htm EX-23.1 1685
8 GRAPHIC g607803page_3b.jpg GRAPHIC 7326
  Complete submission text file 0001193125-13-393080.txt   950798
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-191610 | Film No.: 131139636
SIC: 2834 Pharmaceutical Preparations